Skip to main content
Back
Watch Compare

HEALTHY EXTRACTS INC.

Data quality: 100%
HYEX
OTC Manufacturing Chemicals
$2.00
$0.00 (0.00%)
Mkt Cap: 33.74 M
Price
$2.00
Mkt Cap
33.74 M
Day Range
$2.00 — $2.00
52-Week Range
$0.81 — $4.25
Volume
100
Open $2.00
50D / 200D Avg
$2.12
5.51% below
50D / 200D Avg
$2.07
3.18% below

Quick Summary

Key Takeaways

Revenue grew 28.08% annually over 5 years — strong growth
ROE of 163.99% indicates high profitability
Net margin of 445.95% shows strong profitability
Generating 165,520.0 in free cash flow
P/E of 1.68 — trading at a low valuation
Revenue growth is accelerating — 1Y growth exceeds 5Y average by 16.85%

Growth

Revenue Growth (5Y)
28.08%
Above sector avg (9.35%)
Revenue (1Y)44.93%
Earnings (1Y)4.58%
FCF Growth (3Y)N/A

Quality

Return on Equity
163.99%
Above sector avg (-51.02%)
ROICN/A
Net Margin445.95%
Op. MarginN/A

Safety

Debt / Equity
N/A
Current Ratio1.47
Interest CoverageN/A

Valuation

PE (TTM)
1.68
Above sector avg (-1.98)
P/B Ratio1.40
EV/EBITDAN/A
Dividend YieldN/A

Price History

Financial Trends

Peer Comparison

vs Manufacturing sector median (44 peers)
Metric Stock Sector Median
P/E 1.7 -2.0
P/B 1.4 5.1
ROE % 164.0 -51.0
Net Margin % 446.0 -150.2
Rev Growth 5Y % 28.1 9.3
D/E — 0.3

All Fundamental Metrics
Growth
Revenue Growth (1Y) 44.93% Revenue Growth (3Y) 34.72%
Earnings Growth (1Y) 4.58% Earnings Growth (3Y) 4.75%
Revenue Growth (5Y) 28.08% Earnings Growth (5Y) N/A
Profitability
Revenue (TTM) 4.51 M Net Income (TTM) 20.12 M
ROE 163.99% ROA 140.28%
Gross Margin 53.69% Operating Margin N/A
Net Margin 445.95% Free Cash Flow (TTM) 165,520.0
ROIC N/A FCF Growth (3Y) N/A
Safety
Debt / Equity N/A Current Ratio 1.47
Interest Coverage N/A Asset Turnover 0.31
Working Capital 554,705 Tangible Book Value 23.85 M
Dividends
Dividend Yield N/A Payout Ratio N/A
Dividend Growth (3Y) N/A Dividend Growth (5Y) N/A
Consecutive Div Years N/A
Valuation
P/E Ratio 1.68 Forward P/E N/A
P/B Ratio 1.40 P/S Ratio 7.48
PEG Ratio N/A Forward PEG N/A
EV/EBITDA N/A Fwd EV/EBITDA N/A
Forward P/S N/A Fwd Earnings Yield N/A
FCF Yield 0.49%
Market Cap 33.74 M Enterprise Value 33.74 M
Per Share
EPS (Diluted TTM) N/A Revenue / Share 0.27
FCF / Share 0.01 OCF / Share 0.01
EPS CAGR (1Y) N/A EPS CAGR (5Y) N/A
EPS CAGR (10Y) N/A
Efficiency
CapEx / Revenue N/A FCF Conversion 0.82%
SBC-Adj. FCF N/A Growth Momentum 16.85

Income Statement

Annual, most recent first
Metric FY2025 FY2024 FY2023 FY2022 FY2021
Revenue 4.51 M 3.11 M 2.49 M 2.25 M 1.68 M
Net Income 20.12 M 19.24 M 18.34 M -983,121.0 -1.99 M
EPS (Diluted) — — — — —
Gross Profit 2.42 M 1.91 M 1.62 M 1.37 M 695,078.0
Operating Income — — — — —
EBITDA — — — — —
R&D Expenses — — — — —
SG&A Expenses — — — — —
D&A — — — — 5,100.0
Interest Expense -210,279.0 -186,252.0 -176,948.0 -64,690.0 -52,453.0
Income Tax 0.0 0.0 0.0 — —

Balance Sheet

Annual, most recent first
Metric FY2025 FY2024 FY2023 FY2022 FY2021
Total Assets 27.82 M 2.38 M 2.64 M 2.78 M 3.03 M
Total Liabilities 3.80 M — — — —
Shareholders' Equity 24.03 M 410,377.0 954,590.0 1.88 M 2.47 M
Total Debt — — — — —
Cash & Equivalents — — — — —
Current Assets 1.33 M 1.66 M 1.90 M 1.99 M 2.31 M
Current Liabilities 1.69 M 1.97 M 1.68 M 902,788.0 558,841.0